Skip to main content

Table 3 Multivariable linear regression models for significant predictors of phylloquinone, %ucOC and PIVKA-II

From: Assessment of potential biomarkers of subclinical vitamin K deficiency in patients with end-stage kidney disease

  β Coefficient 95% Confidence interval p
Phylloquinone (R2 = 0.275, n = 42)    
 Triglycerides 0.54 0.25 to 0.84 0.001
 Total cholesterol -0.036 -0.46 to 0.39 0.87
%ucOC (R2 = 0.14, n = 41)    
 Phosphate 14.80 1.71 to 29.13 0.028
 PTH -0.14 -0.26 to -0.02 0.028
 Coronary artery disease -9.14 -18.73 to 0.46 0.061
PIVKA-II (R2 = 0.16, n = 43)    
 Age, years 0.05 0.01 to 0.10 0.033
 Coronary artery disease 1.40 -0.14 to 2.93 0.07
  1. PTH, parathyroid hormone; %ucOC, percentage of uncarboyxlated osteocalcin; PIVKA-II, proteins induced by vitamin K absence or antagonism.